Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Journal of Visualized Experiments : Jove|July 24, 2018
Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in MiceMathilde Beka, Teresinha LealClinical Science (London, England : 1979)|February 16, 2017
Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanismsSabrina Noel, Nadtha Panin, Mathilde Beka, et al.Neuro-Oncology Advances|December 31, 2025
DIAPH3 is upregulated in high-grade gliomas and linked to chromosomal instabilityCaren Jabbour, Mathilde Beka, Philippe Gailly, et al.Frontiers in Pharmacology|October 2, 2012
PDE5 Inhibitors as Potential Tools in the Treatment of Cystic FibrosisSabrina Noel, Barbara Dhooghe, Teresinha LealJournal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 28, 2012
A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential differenceAnissa Leonard, Patrick Lebecque, Jasper Dingemanse, et al.Clinical Biochemistry|June 16, 2012
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapyBob Lubamba, Barbara Dhooghe, Sabrina Noel, et al.Clinical Biochemistry|January 2, 2014
Lung inflammation in cystic fibrosis: pathogenesis and novel therapiesBarbara Dhooghe, Sabrina Noël, François Huaux, et al.Physiotherapy|March 12, 2026
Effect of an airway clearance technique on nebulized drug delivery in patients with CF: A randomized cross-over trialGregory Reychler, Teresinha Leal, Sophie Gohy, et al.Expert Opinion on Investigational Drugs|February 16, 2016
Strategies in early clinical development for the treatment of basic defects of cystic fibrosisBarbara Dhooghe, Jérémy Boris Haaf, Sabrina Noel, et al.Clinical Pharmacology : Advances and Applications|October 6, 2016
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesBéla Z Schmidt, Jérémy B Haaf, Teresinha Leal, et al.Pageof 7